ARCHIVES

Avastin Regimen Bested Chemo Alone In Early Disease

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

James Doroshow Named NCI Deputy Director, Clinical Research

June 10, 2011

Ovarian Cancer Symptom Indices May Need to be Re-Evaluated

January 27, 2012

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Raising NIH Appropriations Is High Priority, House Subcommittee Chairman Says

March 7, 1997

FCRC Committee Limited To Review Of Basic Science

November 26, 1976

In Brief: Cancer Program A “Noble Venture,” Kennedy Says; $937 Million Not Enough, Upton Says

April 13, 1979